O60341 (KDM1A_HUMAN) Homo sapiens (Human)
Lysine-specific histone demethylase 1A UniProtKBInterProSTRINGInteractive Modelling
852 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
114 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of a truncated LSD1:CoREST in the presence of an LSD1-NT peptide |
Heteromer Q9UKL0; | 100 | 1×FAD; | |||
| Human LSD1/CoREST bound to the quinazoline inhibitor MC4106 |
Heteromer Q9UKL0; | 100 | 1×FAD; 3×NY8; 1×PO4; 5×CL; 1×GOL; 1×DMS; | |||
| Structural Basis for CoREST-Dependent Demethylation of Nucleosomes by the Human LSD1 Histone Demeth… |
Heteromer Q9UKL0; | 100 | 1×FAD; 3×CL; 2×GOL; 1×NH4; | |||
| LSD1-CoREST bound to Acetylated K14 of Histone H3 |
Heteromer Q6NXT2; Q9UKL0; | 100 | 1×FAD; | |||
| Human LSD1/CoREST: LSD1 Y761H mutation |
Heteromer Q9UKL0; | 99.85 | 1×FAD; | |||
| LSD1-CoREST in complex with T108, long soaking |
Heteromer Q9UKL0; | 100 | 1×Y0Z; | |||
| LSD1-CoREST in complex with T17, short soaking |
Heteromer Q9UKL0; | 100 | 1×YAF; | |||
| LSD1-CoREST in complex with AW4, long soaking |
Heteromer Q9UKL0; | 100 | 1×SV9; | |||
| LSD1-CoREST in complex with T108, short soaking |
Heteromer Q9UKL0; | 100 | 3×XZU; 1×XZQ; | |||
| LSD1-CoREST in complex with AW2 and SNAG peptide |
Heteromer O95863; Q9UKL0; | 100 | 1×XB6; | |||
| LSD1-CoREST in complex with T108 and SNAG peptide |
Heteromer O95863; Q9UKL0; | 100 | 1×Y0Z; | |||
| LSD1-CoREST1 in complex with quinazoline-derivative reversible inhibitor |
Heteromer Q9UKL0; | 100 | 1×FAD; 5×E11; 1×NA; | |||
| LSD1-CoREST in complex with AW4, short soaking |
Heteromer Q9UKL0; | 100 | 1×Y9K; | |||
| Structure of LSD1:CoREST in complex with ssRNA |
Heteromer Q9UKL0; | 100 | 4×FAD; 20×SO4; 4×GOL; | |||
| LSD1-CoREST in complex with AW4 and SNAG peptide |
Heteromer O95863; Q9UKL0; | 100 | 1×SV9; | |||
| LSD1(KDM1A)-CoREST in complex with Z-Pro derivative of MC2580 |
Heteromer Q9UKL0; | 100 | 1×FAD; 1×M8A; | |||
| LSD1 Y391K-CoREST bound to Acetylated K14 of Histone H3 |
Heteromer Q6NXT2; Q9UKL0; | 99.85 | 1×FAD; | |||
| LSD1-CoREST in complex with T14, long soaking |
Heteromer Q9UKL0; | 100 | 1×XF6; | |||
| LSD1-CoREST in complex with T14, short soaking |
Heteromer Q9UKL0; | 100 | 1×Y66; | |||
| LSD1 Y391K-CoREST bound to Histone H3 N-terminal tail |
Heteromer Q6NXT2; Q9UKL0; | 99.85 | 1×FAD; | |||
| LSD1-CoREST in complex N-formyl FAD and SNAG peptide |
Heteromer O95863; Q9UKL0; | 100 | 1×HUF; | |||
| Crystal structure of a neuro-specific splicing variant of human histone lysine demethylase LSD1. |
Heteromer P68431; Q9UKL0; | 100 | 1×FAD; | |||
| Thieno[3,2-b]pyrrole-5-carboxamides as Novel Reversible Inhibitors of Histone Lysine Demethylase KD… |
Heteromer Q9UKL0; | 100 | 1×FAD; 1×6W3; | |||
| Structure of LSD1-CoREST-Tetrahydrofolate complex |
Heteromer Q9UKL0; | 100 | 1×FAD; 1×GOL; 1×THG; 1×CL; | |||
| Structure of the KDM1A/CoREST complex with the inhibitor 4-ethyl-N-[3-(methoxymethyl)-2-[[4-[[(3R)-… |
Heteromer Q9UKL0; | 100 | 1×FAD; 6×GOL; 1×6X0; | |||
| Structural basis of LSD1-CoREST selectivity in histone H3 recognition |
Heteromer Q16695; Q9UKL0; | 100 | 1×FAD; | |||
| Crystal structure of LSD1-CoREST in complex with para-bromo-(-)-trans- 2-phenylcyclopropyl-1-amine |
Heteromer Q9UKL0; | 100 | 1×FAD; 1×TCF; | |||
| Crystal structure of LSD1-CoREST in complex with (+)-trans-2- phenylcyclopropyl-1-amine |
Heteromer Q9UKL0; | 100 | 1×FAD; 1×3PL; | |||
| LSD1-CoREST1 in complex with polymyxin E (colistin) |
Heteromer Q9UKL0; | 100 | 1×FAD; 2×NA; | |||
| Structure of the KDM1A/CoREST complex with the inhibitor 2-[3-{4-chloro-3-[(4-chlorophenyl)ethynyl]… |
Heteromer Q9UKL0; | 100 | 2×N4K; 1×FAD; 5×GOL; | |||
| LSD1-CoREST in complex with T18, short soaking |
Heteromer Q9UKL0; | 100 | 1×YAO; | |||
| Thieno[3,2-b]pyrrole-5-carboxamides as Novel Reversible Inhibitors of Histone Lysine Demethylase KD… |
Heteromer Q9UKL0; | 100 | 1×FAD; 1×6W1; | |||
| LSD1/CoREST bound to bomedemstat |
Heteromer Q9UKL0; | 100 | 1×A1IG2; | |||
| Crystal structure of LSD1-CoREST in complex with a tranylcypromine derivative (MC2580, 14e) |
Heteromer Q9UKL0; | 100 | 1×FAD; 1×M80; | |||
| Crystal structure of LSD1-CoREST in complex with a tranylcypromine derivative (MC2584, 13b) |
Heteromer Q9UKL0; | 100 | 1×FAD; 1×M84; | |||
| Crystal structure of LSD1-CoREST in complex with para-bromo-(+)-cis-2- phenylcyclopropyl-1-amine |
Heteromer Q9UKL0; | 100 | 1×FAD; 1×TCF; | |||
| Human LSD1/CoREST: LSD1 D556G mutation |
Heteromer Q9UKL0; | 99.85 | 1×FAD; | |||
| Crystal structure of LSD1-CoREST in complex with (-)-trans-2- phenylcyclopropyl-1-amine |
Heteromer Q9UKL0; | 100 | 1×FAD; 1×TCA; | |||
| LSD1-CoREST1 in complex with quinazoline-derivative reversible inhibitor |
Heteromer Q9UKL0; | 100 | 1×FAD; 3×767; | |||
| Human LSD1/CoREST: LSD1 E379K mutation |
Heteromer Q9UKL0; | 99.85 | 1×FAD; | |||
| Structure of the KDM1A/CoREST complex with the inhibitor 4-methyl-N-[4-[[4-(1-methylpiperidin-4-yl)… |
Heteromer Q9UKL0; | 100 | 1×FAD; 4×GOL; 2×6X3; | |||
| Structure of the KDM1A/CoREST complex with the inhibitor N-[3-(ethoxymethyl)-2-[[4-[[(3R)-pyrrolidi… |
Heteromer Q9UKL0; | 100 | 1×FAD; 1×6X5; 2×GOL; | |||
| LSD1-CoREST1 in complex with polymyxin B |
Heteromer Q9UKL0; | 100 | 1×FAD; | |||
| Crystal structure of the LSD1/CoREST histone demethylase bound to its nucleosome substrate |
Heteromer P02281; P06897; P62799; P84233; Q9UKL0; | 99.55 | 2×FAD; | |||
| Human LSD1 Histone Demethylase-CoREST in complex with an FAD- tranylcypromine adduct |
Heteromer Q9UKL0; | 100 | 1×FAJ; 2×GOL; 1×CL; | |||
| LSD1-CoREST in complex with T105 |
Heteromer Q9UKL0; | 100 | 1×XHT; 1×XHX; | |||
| Crystal structure of LSD1-CoREST in complex with a N-terminal SNAIL peptide |
Heteromer O95863; Q9UKL0; | 100 | 1×FAD; | |||
| Phosphomimetic mutant of LSD1-8a splicing variant in complex with CoREST |
Heteromer Q9UKL0; | 100 | 1×FAD; | |||
| Thieno[3,2-b]pyrrole-5-carboxamides as Novel Reversible Inhibitors of Histone Lysine Demethylase KD… |
Heteromer Q9UKL0; | 100 | 1×FAD; 1×6W0; | |||
| Structural Basis of Histone Demethylation by LSD1 Revealed by Suicide Inactivation |
Heteromer P68431; Q9UKL0; | 100 | 1×FDA; 1×GOL; 2×CL; | |||
| LSD1-CoREST in complex with AW2, short soaking |
Heteromer Q9UKL0; | 100 | 1×XB3; | |||
| LSD1-CoREST in complex with AW2, long soaking |
Heteromer Q9UKL0; | 100 | 1×XB6; | |||
| Structure of the 2a splicing variant of the full-length human LSD1 bound to CoREST (delta305) |
Heteromer Q9UKL0; | 100 | 1×FAD; | |||
| LSD1(KDM1A)-CoREST in complex with 1-Benzyl-Tranylcypromine |
Heteromer Q9UKL0; | 100 | 1×D69; | |||
| LSD1(KDM1A)-CoREST in complex with 1-Methyl-Tranylcypromine (1S,2R) |
Heteromer Q9UKL0; | 100 | 1×D51; | |||
| LSD1-CoREST in complex with PRSFAA peptide |
Heteromer Q9UKL0; | 100 | 1×FAD; | |||
| LSD1(KDM1A)-CoREST in complex with 1-Methyl-Tranylcypromine (1R,2S) |
Heteromer Q9UKL0; | 100 | 1×D73; | |||
| LSD1-CoREST in complex with INSM1 peptide |
Heteromer Q01101; Q9UKL0; | 100 | 1×FAD; | |||
| Histone demethylase LSD1(KDM1A)-CoREST3 Complex |
Heteromer Q9P2K3; | 100 | 1×FAD; | |||
| LSD1(KDM1A)-CoREST in complex with 1-Ethyl-Tranylcypromine |
Heteromer Q9UKL0; | 100 | 1×D70; | |||
| LSD1-CoREST in complex with PLSFLV peptide |
Heteromer Q9UKL0; | 100 | 1×FAD; | |||
| LSD1-CoREST in complex with PRSFAV peptide |
Heteromer Q9UKL0; | 100 | 1×FAD; | |||
| LSD1(KDM1A)-CoREST in complex with 1-Phenyl-Tranylcypromine |
Heteromer Q9UKL0; | 100 | 1×D52; | |||
| LSD1-CoREST in complex with PRSFLV peptide |
Heteromer Q9UKL0; | 100 | 1×FAD; | |||
| LSD1-CoREST in complex with PRLYLV peptide |
Heteromer Q9UKL0; | 100 | 1×FAD; | |||
| LSD1-CoREST in complex with PKSFLV peptide |
Heteromer Q9UKL0; | 100 | 1×FAD; | |||
| Crystal structure of LSD1-CoREST in complex with peptide 13 |
Heteromer P68431; Q9UKL0; | 100 | 1×FAD; 2×GOL; | |||
| Crystal structure of LSD1-CoREST in complex with peptide 9 |
Heteromer P68431; Q9UKL0; | 100 | 1×FAD; 3×GOL; | |||
| LSD1/CoREST1 complex with macrocyclic peptide inhibitor |
Heteromer Q9UKL0; | 100 | 1×FAD; | |||
| Crystal structure of Lysine Specific Demethylase 1 (LSD1) with TAS1440 |
Heteromer Q9UKL0; | 100 | 1×FAD; 2×GOL; 1×UEU; | |||
| Crystal structure of LSD1-CoREST in complex with peptide 11 |
Heteromer P68431; Q9UKL0; | 100 | 4×GOL; 1×FAD; | |||
| LSD1-CoREST-S2116 five-membered ring adduct model |
Heteromer Q9UKL0; | 100 | 5×GOL; 1×DJ0; 1×FAD; | |||
| LSD1-CoREST-S2116 N5 adduct model |
Heteromer Q9UKL0; | 100 | 5×GOL; 1×DJ0; 1×FAD; | |||
| Crystal structure of LSD1-CoREST in complex with PRSFLVRRP peptide |
Heteromer Q9UKL0; | 100 | 1×FAD; 2×GOL; | |||
| Crystal structure of LSD1-CoREST in complex with PRSFLVRRK peptide |
Heteromer Q9UKL0; | 100 | 1×FAD; 3×GOL; | |||
| Crystal structure of LSD1-CoREST in complex with PRSFLVRKR peptide |
Heteromer Q9UKL0; | 100 | 1×FAD; 5×GOL; | |||
| LSD1-CoREST-S2101 N5 adduct model |
Heteromer Q9UKL0; | 100 | 3×GOL; 1×DJ0; 1×FAD; | |||
| LSD1-CoREST-S2101 five-membered ring adduct model |
Heteromer Q9UKL0; | 100 | 3×GOL; 1×DJ0; 1×FAD; | |||
| Crystal structure of LSD1-CoREST in complex with PRSFLVRR peptide |
Heteromer Q9UKL0; | 100 | 1×FAD; 2×GOL; | |||
| Crystal structure of LSD1-CoREST in complex with PRSFLVRRR peptide |
Heteromer Q9UKL0; | 100 | 1×FAD; 4×GOL; | |||
| LSD1/Co-Rest structure with an inhibitor |
Heteromer Q9UKL0; | 100 | 1×CW0; 1×DTT; 2×ACT; 3×MLA; 4×GOL; 1×D3U; 12×EDO; 3×PEG; 2×CL; | |||
| LSD1-CoREST in complex with 4-[5-(piperidin-4-ylmethoxy)-2-(p-tolyl)pyridin-3-yl]benzonitrile |
Heteromer Q9UKL0; | 100 | 1×FAD; 1×8WC; 2×GOL; | |||
| Crystal structure of Lysine Specific Demethylase 1 (LSD1) with JH-45 |
Heteromer Q9UKL0; | 99.85 | 1×FAD; 1×A1LZJ; | |||
| Crystal structure of Lysine Specific Demethylase 1 (LSD1) with CC-90011 |
Heteromer Q9UKL0; | 100.0 | 1×V0Y; 1×FAD; | |||
| Crystal structure of Importin alpha 2 in complex with LSD1 NLS S111E mutant |
Heteromer P52293; | 88.89 | 4×GOL; | |||
| Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation |
Heteromer O14646; | 100 | 9×EDO; 3×CL; | |||
| Crystal structure of Importin alpha 2 in complex with LSD1 NLS |
Heteromer P52293; | 100 | 1×CL; | |||
| Crystal structure of Importin Alpha 3 in complex with human LSD1 NLS |
Heteromer O00629; | 100 | ||||
| Swirm domain of human Lsd1 | homo-2-mer | 100 | ||||
| Crystal Structure and Mechanism of human Lysine-Specific Demethylase-1 | monomer | 100.0 | 3×HG; 1×FAD; | |||
| Crystal structure of Lysine Specific Demethylase 1 (LSD1) with TAK-418, FAD-adduct | monomer | 100.0 | 1×HUF; 1×GOL; 2×IMD; 2×MG; | |||
| Crystal Structure of LSD1 in complex with a 2-PCPA derivative, S1201 | monomer | 100.0 | 1×12F; | |||
| LSD1-S2157 five-membered ring adduct model | monomer | 100.0 | 6×GOL; 1×TLA; 1×DJ0; 1×FAD; | |||
| LSD1-S2157 N5 adduct model | monomer | 100.0 | 6×GOL; 1×TLA; 1×DJ0; 1×FAD; | |||
| LSD1-FCPA-MPE five-membered ring adduct model | monomer | 100.0 | 1×MPD; 1×DJC; 1×FAD; | |||
| LSD1-FCPA-MPE N5 adduct model | monomer | 100.0 | 1×MPD; 1×DJC; 1×FAD; | |||
| Crystal structure of LSD1 in complex with cis-4-Br-2,5-F2-PCPA (S1024) | monomer | 100.0 | 1×FAD; 1×8A2; 1×TLA; 6×GOL; | |||
| LSD1 in complex with S2172 | monomer | 100.0 | 1×TLA; 5×GOL; 1×DJ0; 1×FAD; | |||
| Crystal structure of LSD1 in complex with compound 5 | monomer | 100.0 | 4×GOL; 1×TLA; 1×7UW; 1×FAD; | |||
| Crystal structure of LSD1 in complex with compound S1427 | monomer | 100.0 | 4×GOL; 1×TLA; 1×7UQ; 1×FAD; | |||
| Crystal structure of LSD1 in complex with compound 4 | monomer | 100.0 | 4×GOL; 1×TLA; 1×7UQ; 1×FAD; | |||
| Crystal structure of Lysine-specific demethylase1 | monomer | 100.0 | 1×F2N; | |||
| Crystal structure of Lysine-specific histone demethylase 1 | monomer | 100.0 | 1×FAJ; | |||
| Crystal structure of Lysine Specific Demethylase 1 (LSD1) with TAK-418 distomer, FAD-adduct | monomer | 100.0 | 1×GOL; 2×MG; 1×FA8; 1×I00; | |||
| Crystal structure of human LSD1 at 2.3 A resolution | monomer | 100.0 | 1×FAD; | |||
| LSD1-tranylcypromine complex | monomer | 100.0 | 1×F2N; | |||
| Crystal structure of LSD1 | monomer | 99.84 | 1×FAD; | |||
| Crystal Structure of LSD1 in complex with trans-2-pentafluorophenylcyclopropylamine | monomer | 100.0 | 1×2PF; | |||
| Human LSD1 in complex with GSK2879552 | monomer | 100.0 | 1×KWM; | |||
| Crystal structure of Human LSD1 | monomer | 100.0 | 1×FAD; | |||
| Human LSD1 in complex with Phenelzine sulfate | monomer | 100.0 | 1×KXM; | |||
| The solution structure of the SWIRM domain of human LSD1 | monomer | 100 | ||||
| The solution structure of the short form SWIRM domain of LSD1 | monomer | 100 | ||||
| Crystal structure of the SWIRM domain of human histone lysine-specific demethylase LSD1 | monomer | 100 | 1×SO4; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5l3d.1.A | monomer | 0.89 | 99.88 | |||
1 SWISS-MODEL model built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 3zmu.1.A | monomer | 0.88 | 1×PRO; 1×FAD; | 100.00 | ||